Nicolas Mach

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Prognostic Factors

Sentinel Lymph Node

Neoadjuvant Chemotherapy

Top Venues

Cancer research communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Brian Schulte, Nicolas Mach, Timothée Olivier
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcomas: Looking Forward to What Is Next. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Brian Schulte, Nicolas Mach, Timothée Olivier
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcomas: Looking Forward to What Is Next. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A first-in-human phase I clinical study with MVX-ONCO-1, a personalized active immunotherapy, in patients with advanced solid tumors. Cancer research communications (2024)
Natacha Bordry, Anne-Claire Mamez, Chiara Fedeli, Chloé Cantero, Cyril Jaksic, Pilar Ustero Alonso, Caroline Rayroux, Gregory Berra, Vera Portillo, Maeva Puntel, Sabine Yerly, Sébastien Bugeia, Garance Gutknecht, Mariagrazia Di Marco, Nicolas Mach, Paola Marina Soccal, Yves Chalandon, Alexandra Calmy, Alfredo Addeo
SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients. Vaccines 11 (8) (2023)
Richard Cathomas, Sacha I Rothschild, Stefanie Hayoz, Lukas Bubendorf, Berna C Özdemir, Bernhard Kiss, Andreas Erdmann, Stefanie Aeppli, Nicolas Mach, Räto T Strebel, Boris Hadaschik, Dominik Berthold, Hubert John, Deborah Zihler, Mathias Schmid, Ilaria Alborelli, Martina Schneider, Jana Musilova, Martin Spahn, Ulf Petrausch
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Markus Joerger, Yannis Metaxas, Khalil Zaman, Olivier Michielin, Nicolas Mach, Adrienne Bettini, Andreas Michael Schmitt, Nathan Cantoni, Clemens B Caspar, Sonja Stettler, Roma Malval, Miklos Pless, Christian Britschgi, Christoph Renner, Dieter Koeberle, Jessica D Schulz, Christoph Kopp, Stefanie Hayoz, Anastasios Stathis, Roger von Moos, null null
Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA). Cancers 14 (9) (2022)
Anastasios Stathis, Ulrich Mey, Sämi Schär, Felicitas Hitz, Christiane Pott, Nicolas Mach, Fatime Krasniqi, Urban Novak, Christian Schmidt, Karin Hohloch, Dirk Lars Kienle, Dagmar Hess, Alden A Moccia, Michael Unterhalt, Katrin Eckhardt, Stefanie Hayoz, Gabriela Forestieri, Davide Rossi, Stefan Dirnhofer, Luca Ceriani, Giulio Sartori, Francesco Bertoni, Christian Buske, Emanuele Zucca, Wolfgang Hiddemann
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma. Blood advances 6 (13) (2022)
Curigliano Giuseppe, André B P van Kuilenburg, Nicolas Mach, Toshihiko Doi, David Tai, Patrick M Forde, John Sarantopoulos, Philippe L Bedard, Chia-Chi Lin, F Stephen Hodi, Sofie Wilgenhof, Armando Santoro, Catherine A Sabatos-Peyton, Tyler A Longmire, Alexandros Xyrafas, Haiying Sun, Sabine Gutzwiller, Luigi Manenti, Aung Naing
Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (13) (2021)
Sacha I Rothschild, Alfred Zippelius, Eric I Eboulet, Spasenija Savic Prince, Daniel Betticher, Adrienne Bettini, Martin Früh, Markus Joerger, Didier Lardinois, Hans Gelpke, Laetitia A Mauti, Christian Britschgi, Walter Weder, Solange Peters, Michael Mark, Richard Cathomas, Adrian F Ochsenbein, Wolf-Dieter Janthur, Christine Waibel, Nicolas Mach, Patrizia Froesch, Martin Buess, Pierre Bohanes, Gilles Godar, Corinne Rusterholz, Michel Gonzalez, Miklos Pless, null null
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)
Kevin J Harrington, Anthony Kong, Nicolas Mach, Jason A Chesney, Beatriz Castelo Fernandez, Danny Rischin, Ezra E W Cohen, Hoi-Shen Radcliffe, Burak Gumuscu, Jonathan Cheng, Wendy Snyder, Lillian L Siu
Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)